Back to top
more

SCYNEXIS, Inc. (SCYX)

(Delayed Data from NSDQ)

$4.57 USD

4.57
71,421

-0.12 (-2.56%)

Updated Sep 25, 2020 04:00 PM ET

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.44%
2Buy17.91%
3Hold9.42%
4Sell4.91%
5Strong Sell1.79%
S&P50010.66%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth A Momentum F VGM

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 28% (180 out of 250)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Zacks News

Zacks Equity Research

Will SCYNEXIS Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor in SCYNEXIS.

Zacks Equity Research

Scynexis (SCYX) Reports Q3 Loss, Lags Revenue Estimates

Scynexis (SCYX) delivered earnings and revenue surprises of 4.55% and -100.00%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Analysts Estimate Scynexis (SCYX) to Report a Decline in Earnings: What to Look Out for

Scynexis (SCYX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Implied Volatility Surging for SCYNEXIS (SCYX) Stock Options

Investors need to pay close attention to SCYNEXIS (SCYX) stock based on the movements in the options market lately.

Zacks Equity Research

Scynexis (SCYX) Reports Q2 Loss, Misses Revenue Estimates

Scynexis (SCYX) delivered earnings and revenue surprises of 11.11% and -5.00%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Scynexis (SCYX) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

Scynexis (SCYX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Scynexis (SCYX) Reports Q1 Loss, Misses Revenue Estimates

Scynexis (SCYX) delivered earnings and revenue surprises of -20.00% and -24.71%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Scynexis (SCYX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Scynexis (SCYX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Scynexis (SCYX) Reports Q3 Loss, Tops Revenue Estimates

Scynexis (SCYX) delivered earnings and revenue surprises of 30.00% and 6.67%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Will Scynexis (SCYX) Report Negative Earnings Next Week? What You Should Know

Scynexis (SCYX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Scynexis (SCYX) Reports Q2 Loss, Lags Revenue Estimates

Scynexis (SCYX) delivered earnings and revenue surprises of -64.29% and -20.00%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

What's in the Cards for Perrigo (PRGO) This Earnings Season?

Perrigo's (PRGO) product purchases and introductions in the Rx segment are expected to boost sales.